Male sexual dysfunction in diabetes mellitus

Barry M. Mason, Albert C. Leung, Michael E. Disanto, Arnold Melman

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Male sexual dysfunction can be classified according to the following categories: erectile dysfunction (ED), orgasmic, ejaculatory dysfunction, priapism, and decreased libido. Of these various disorders, medical therapy for ED is the most advanced. ED, also known as impotence, is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual function.1 In recent years, there has been an escalating public awareness of the magnitude of ED, partly attributable to the advent of Viagra™, Levitra™, and Cialis ™ and their associated marketing. The impact of ED is significant as its prevalence in men aged 40-70 years old was estimated at 52% by the Massachusetts Male Aging Study. Based on these data and the US population projection for the year 2020 of more than 62 million men 45-84 years old, ED will affect more than 31 million men and millions more over the age of 84.2,3 The projected worldwide prevalence of ED for the year 2025 will be staggering at 322 million men.

Original languageEnglish (US)
Title of host publicationPrinciples of Diabetes Mellitus
PublisherSpringer US
Pages401-417
Number of pages17
ISBN (Print)9780387098401
DOIs
StatePublished - 2010

Fingerprint

Erectile Dysfunction
Diabetes Mellitus
Priapism
Libido
Marketing

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mason, B. M., Leung, A. C., Disanto, M. E., & Melman, A. (2010). Male sexual dysfunction in diabetes mellitus. In Principles of Diabetes Mellitus (pp. 401-417). Springer US. https://doi.org/10.1007/978-0-387-09841-8-26

Male sexual dysfunction in diabetes mellitus. / Mason, Barry M.; Leung, Albert C.; Disanto, Michael E.; Melman, Arnold.

Principles of Diabetes Mellitus. Springer US, 2010. p. 401-417.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mason, BM, Leung, AC, Disanto, ME & Melman, A 2010, Male sexual dysfunction in diabetes mellitus. in Principles of Diabetes Mellitus. Springer US, pp. 401-417. https://doi.org/10.1007/978-0-387-09841-8-26
Mason BM, Leung AC, Disanto ME, Melman A. Male sexual dysfunction in diabetes mellitus. In Principles of Diabetes Mellitus. Springer US. 2010. p. 401-417 https://doi.org/10.1007/978-0-387-09841-8-26
Mason, Barry M. ; Leung, Albert C. ; Disanto, Michael E. ; Melman, Arnold. / Male sexual dysfunction in diabetes mellitus. Principles of Diabetes Mellitus. Springer US, 2010. pp. 401-417
@inbook{0c31cbbd7b4048a38a67835f4477dd51,
title = "Male sexual dysfunction in diabetes mellitus",
abstract = "Male sexual dysfunction can be classified according to the following categories: erectile dysfunction (ED), orgasmic, ejaculatory dysfunction, priapism, and decreased libido. Of these various disorders, medical therapy for ED is the most advanced. ED, also known as impotence, is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual function.1 In recent years, there has been an escalating public awareness of the magnitude of ED, partly attributable to the advent of Viagra™, Levitra™, and Cialis ™ and their associated marketing. The impact of ED is significant as its prevalence in men aged 40-70 years old was estimated at 52{\%} by the Massachusetts Male Aging Study. Based on these data and the US population projection for the year 2020 of more than 62 million men 45-84 years old, ED will affect more than 31 million men and millions more over the age of 84.2,3 The projected worldwide prevalence of ED for the year 2025 will be staggering at 322 million men.",
author = "Mason, {Barry M.} and Leung, {Albert C.} and Disanto, {Michael E.} and Arnold Melman",
year = "2010",
doi = "10.1007/978-0-387-09841-8-26",
language = "English (US)",
isbn = "9780387098401",
pages = "401--417",
booktitle = "Principles of Diabetes Mellitus",
publisher = "Springer US",

}

TY - CHAP

T1 - Male sexual dysfunction in diabetes mellitus

AU - Mason, Barry M.

AU - Leung, Albert C.

AU - Disanto, Michael E.

AU - Melman, Arnold

PY - 2010

Y1 - 2010

N2 - Male sexual dysfunction can be classified according to the following categories: erectile dysfunction (ED), orgasmic, ejaculatory dysfunction, priapism, and decreased libido. Of these various disorders, medical therapy for ED is the most advanced. ED, also known as impotence, is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual function.1 In recent years, there has been an escalating public awareness of the magnitude of ED, partly attributable to the advent of Viagra™, Levitra™, and Cialis ™ and their associated marketing. The impact of ED is significant as its prevalence in men aged 40-70 years old was estimated at 52% by the Massachusetts Male Aging Study. Based on these data and the US population projection for the year 2020 of more than 62 million men 45-84 years old, ED will affect more than 31 million men and millions more over the age of 84.2,3 The projected worldwide prevalence of ED for the year 2025 will be staggering at 322 million men.

AB - Male sexual dysfunction can be classified according to the following categories: erectile dysfunction (ED), orgasmic, ejaculatory dysfunction, priapism, and decreased libido. Of these various disorders, medical therapy for ED is the most advanced. ED, also known as impotence, is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual function.1 In recent years, there has been an escalating public awareness of the magnitude of ED, partly attributable to the advent of Viagra™, Levitra™, and Cialis ™ and their associated marketing. The impact of ED is significant as its prevalence in men aged 40-70 years old was estimated at 52% by the Massachusetts Male Aging Study. Based on these data and the US population projection for the year 2020 of more than 62 million men 45-84 years old, ED will affect more than 31 million men and millions more over the age of 84.2,3 The projected worldwide prevalence of ED for the year 2025 will be staggering at 322 million men.

UR - http://www.scopus.com/inward/record.url?scp=84892350481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892350481&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-09841-8-26

DO - 10.1007/978-0-387-09841-8-26

M3 - Chapter

SN - 9780387098401

SP - 401

EP - 417

BT - Principles of Diabetes Mellitus

PB - Springer US

ER -